MSET.NEO

Mindset Pharma (MSET.C) announced they have filed a new patent with the US Patent and Trade Office (USPTO), extending its Family 4 compounds, a set of novel DMT/5-MeO-DMT analogs….
Mindset Pharma (MSET.C) announced their lead clinical candidate, MSP-1014. MSP-1014 is a differentiated psilocybin-based compound from Mindset’s Family 1 of novel, patent-pending psychedelic compounds. MSET plans on moving forward…
Mindset Pharma (MSET.C) announced that their in vivo (in an animal) testing carried out by InterVivo Solutions confirmed that the majority of their patent-pending compounds created effects that correlate…
Mindset Pharma (MSET.C) announced they have completed their $7.5 million “bought deal” public offering. The offering issued 10,000,000 units sold at $0.75 each. Each unit granted the buyer one…
There are two options when it comes to ingesting psychedelics, natural or synthetic.   People have been tripping balls eating raw natural mushrooms for thousands of years, so why…
Mother nature   Am I a true hippy, or do I have an impulsive personality that morphs and changes due to a lack of identity?   My therapist thinks…
Our mental health is deteriorating    More and more people are seeking help as anxiety, depression, and suicide are on the rise in 2021.   According to a recent…